fatase-hydrolyzable conjugates of homovanilliC acid, 3,4-dihydroxyphenylacetic acid, p-hydroxyphenylacetiC acid, and vanillic acid in the urine of 20 apparently normal and healthy control persons and of three patients with neuroblastoma. We used organic solvent extraction and capillary gas chromatography. There was considerable person-to-person variation in the conjugation percentages calculated. Mean conjugated percentages of the four compounds for 16 normal healthy persons 2.5-40 years of age were, respectively, 12%, 33%, 14%, and 35%. For newborns and patients with neuroblastoma, these percentages were somewhat different. Increased amounts of vanillic acid were found in the urine of the patients with neuroblastoma, but results of a small metabolic study in rats suggest that this increase most probably is of dietary origin. Using capillary gas chromatography, we undertook a study on the conjugation percentages of urinary HVA and DOPAC (both metabolites of dopamine), p-hydroxyphenylacetic acid (pOHPAA, a tyrosine metabolite), and vanillic acid (VA). In addition, some comment is given on the origin of urinary VA. ' 
Materials and Methods
Standards, Reagents, and Equipment 
Derivatization.
Derivatize tbe above residues and standards in 200 1tLof bis(trimethylsilyl)trifluoroacetamide by heating at 80 #{176}C for 10 mm.
Gas-chromatographic analysis.
Inject 0.4-zL aliquots into a gas chromatograph programmed for 10 mm at 70 #{176}C, 3 #{176}C/min to 240 #{176}C, and 5 mm at 240 #{176}C. The splitter ratio is 1:5.
Quantification.
Calculate excretion values on the basis of peak heights, with propyl gallate as an internal standard, and express results in terms of creatinine.
For quality control, enrich random urine samples with known amounts of the compounds to be measured, before extraction.
We determined urinary VMA and MOPEG as described previously, with use of packed columns (4). In those cases in which large amounts of VMA were excreted, they were calculated from data obtained by use of the capillary column.
Results and Discussion
Amounts of the free (i.e., unconjugated) compounds were measured on the basis of the assumption that the clean-up procedure described does not lead to co-extraction of glucurono or sulfate conjugates, or both, as the derivatization of these compounds most certainly would lead to the same derivatives as those obtained with their free analogs (5) . Lacking reference conjugates, we were unable to check for completeness of the enzymatic hydrolysis or for the presence of enzyme inhibitors. Only f3-glucuronidaseand sulfatase-hydrolyzable conjugates were studied. The conjugation of urinary VMA could not be studied, because this compound was contaminated even on capillary OV-1 columns. However, from the present and previous (unpublished) results we obtained the impression that VMA is excreted only as the free compound.
There were no differences in the extraction recovery of reference compounds added to hydrolyzed and non-hydrolyzed urines before extraction, nor did we observe significant degradation of reference compounds added to urine samples before hydrolysis and taken through the procedure. No corrections were made for the small differences in the extraction recovery of the compounds measured and the internal standard. higher conjugation percentages of HVA and DOPAC and lower conjugation percentages of VA. The three patients with neuroblastoma showed relatively high conjugation percentages of VA and low conjugation percentages of DOPAC.
In general, there was considerable person-to-person variation in the percentages of these structurally related organic acids that were conjugated. At least part of this variation can be ascribed to faults that occur when relatively small conjugation percentages are calculated from the differences in free and total amounts. In three cases, we calculated "negative" conjugation percentages (HVA twice and VA once; minimum: -10%). No further attempts were made to assess the uncertainty in the conjugation percentages calculated. The high urinary excretion of VA by some patients with neuroblastoma (Table 1) made us wonder about the origin of this compound. One of these patients (no. 2), suffering from a non-catecholamine-secreting neuroblastoma originating from the dorsal roots, alternately excreted increased and normal amounts of VA, without a clear indication for large differences in the ingestion of vanillin (the major component of vanilla flavoring). Figure 4 shows part of a gas chromatogram of an extract of urine from this patient in which large amounts of VA could be demonstrated. Reportedly, urinary VA can be considered as a minor end metabolite of norepibeen stored at pH 1.0 and -20 #{176}C for 17 months before analysis. The presence of a "normal" amount of organic acid conjugates in this sample suggests that, in contrast to the conjugates of MOPEG (7), most of these conjugates are resistant to spontaneous hydrolysis at pH 1.0 and -20 #{176}C. Figure 3 shows the conjugation percentages calculated for 20 normal control persons and for three patients with neuroblastoma. Mean percentages for 16 persons, 2.5-40 years of age, were: pOHPAA-14% (range: 2-52%); VA-35% (0-59%); HVA-12% (0-31%); and DOPAC-33% (15-52%). For four two-day-old infants, these data were: pOHPAA-22% (11-42%); VA-22% (7-36%); HVA-28% (23-31%); and DOPAC-54% (38-72%). Newborns showed a tendency to (8, 10) . Several other potential dietary sources for urinary VA have been reported (8) . The results obtained from the following experiments support the suggestion that VA can be derived metabolically from vanillin. The two rats injected with MOPEG and VMA did not show clearly increased excretions of VA in the first 24 h (less than 0.1% of the injected VMA and MOPEG was excreted as excess VA). On the other hand, the rat injected with vanillin excreted 0.9 mg of VA in excess of the normal output in the first 24 h (corresponding to 9% of the injected amount of vanillin; 42% was in the conjugated form).
In addition, the following data were obtained from these experiments. In the first 24 h after injection, the rat that received VMA excreted 4.0 mg of VMA in excess of the normal output (conjugation percentage: 0%). For the rat injected with MOPEG this figure was 5.1 mg of MOPEG (conjugation percentage: 98%). A relatively small amount of MOPEG was oxidized to VMA (0.2 mg in the first 24 h, which equals 2% of the amount injected). From the latter percentage it can be concluded that in the rat the conversion of MOPEG to VMA is quantitatively a less important pathway than the corresponding oxidation of 3-methoxy-4-hydroxyphenylethanol to HVA (11) .
We conclude that relatively large amounts of conjugated VA and DOPAC (±34%) and relatively small amounts of conjugated pOHPAA and HVA (±13%) are excreted in urine, in a /3-glucuronidase/sulfatase hydrolyzable form. With respect to the diagnosis of neurogenic tumors, the conjugated fractions of HVA and DOPAC cannot be expected to cause severe false-negative results in determinations in which only free amounts are measured. However, for the correct interpretation of borderline values obtained from such determinations it might be of importance to realize that these conjugation percentages seem to be rather variable.
A major part of increased urinary VA may be derived from ingested vanillin by the action of intestinal bacteria or endogenous oxidizing enzymes, or both.
